311 filings
Page 11 of 16
3
ep250o 5ls9pb2n
14 Jun 17
Aeglea BioTherapeutics / Aaron Schuchart ownership change
12:00am
8-K
xqym55zq
9 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
424B5
3871rbfw0qi2
6 Jun 17
Prospectus supplement for primary offering
12:00am
8-K
9aysab85qh3 n3
6 Jun 17
Aeglea BioTherapeutics Prices Public Offering of Common Stock
12:00am
424B5
k4gw4uf
5 Jun 17
Prospectus supplement for primary offering
12:00am
424B5
lugc84dl8j cn1a9
31 May 17
Prospectus supplement for primary offering
12:00am
EFFECT
33n3fbyljg69pwbgx1vt
30 May 17
Notice of effectiveness
12:00am
CORRESP
f81se skldiead5j79
25 May 17
Correspondence with SEC
12:00am
S-3/A
vy5l97vx
23 May 17
Shelf registration (amended)
12:00am
UPLOAD
ffupt qhwd
22 May 17
Letter from SEC
12:00am
CORRESP
7rzqulnfsv1xu5 u2i
18 May 17
Correspondence with SEC
12:00am
CORRESP
nc6qpgrclf pxl
12 May 17
Correspondence with SEC
12:00am
UPLOAD
wulg2ud64dl myrz0r5
10 May 17
Letter from SEC
12:00am
8-K
fcl3os1m41zcs12v zx
9 May 17
Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2017 Financial Results
12:00am
S-3
4ely 2npzgw
1 May 17
Shelf registration
12:00am
CT ORDER
7cuq76dslu89mq7t0r7
25 Apr 17
Confidential treatment order
12:00am
4
qfzulav3t7 3an20ni
25 Apr 17
Aeglea BioTherapeutics / Anthony Quinn ownership change
12:00am
8-K
6x7tweq 33r
21 Apr 17
Regulation FD Disclosure
12:00am
DEF 14A
vdhvrxhknl00c5jkxopu
21 Apr 17
Definitive proxy
12:00am